Suggestions
Suzanne Vernon
Empowering Patients, Advancing Research, and Improving Clinical Care for all those impacted by ME/CFS and Fibromyalgia
Suzanne D. Vernon, PhD, is a prominent researcher and advocate in the field of ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) and Fibromyalgia.13 She currently serves as the Research Director at the Bateman Horne Center of Excellence, a position she has held since 2015.5
Dr. Vernon's career has been dedicated to advancing research and improving clinical care for patients affected by ME/CFS and Fibromyalgia.2 Her journey in the field began during her time at the Centers for Disease Control and Prevention (CDC), where she worked from 1990 to 2007.6 At the CDC, she led a team focused on identifying novel pathogens and diagnostic markers for chronic fatigue syndrome.3
After her time at the CDC, Dr. Vernon served as the Scientific Director of the Solve ME/CFS Initiative (formerly CFIDS Association of America) from 2007 to 2015.6 During this period, she established the Research Institute Without Walls (RIWW), a patient-centered research initiative aimed at identifying diagnostic biomarkers and treatments for ME/CFS.6
At the Bateman Horne Center, Dr. Vernon is instrumental in building a research program focused on identifying biomarkers, developing diagnostic tests, and uncovering evidence-based treatments for ME/CFS.1 She is known for her ability to attract top scientists to the field and for setting up the clinical research core at the center.1
Dr. Vernon has also been involved in research related to long COVID, participating in the RECOVER Initiative's task force on Commonalities with Other Disorders and Post-viral Syndromes.4 Her expertise in ME/CFS has been valuable in understanding the similarities between ME/CFS and long COVID.4
Throughout her career, Dr. Vernon has authored and co-authored numerous scientific papers, contributing significantly to the understanding of ME/CFS and related conditions.6 Her work spans various aspects of the disease, including gene expression, immune function, and diagnostic criteria.6
